Similar Articles
311 Exploring the pharmacological mechanism of Wuzhuyu decoction on hepatocellular carcinoma using network pharmacology
312 Prognostic model of hepatocellular carcinoma based on cancer grade
313 Triplet regimen as a novel modality for advanced unresectable hepatocellular carcinoma: A case report and review of literature
314 Mapping research trends of transarterial chemoembolization for hepatocellular carcinoma from 2012 to 2021: A bibliometric analysis
315 Cellular senescence throws new insights into patient classification and pharmacological interventions for clinical management of hepatocellular carcinoma
316 Fibrinogen-to-albumin ratio predicts overall survival of hepatocellular carcinoma
317 Suberoylanilide hydroxamic acid upregulates reticulophagy receptor expression and promotes cell death in hepatocellular carcinoma cells
318 High spindle and kinetochore-associated complex subunit-3 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma
319 Long-term survival of patients with hepatocellular carcinoma with hepatic, pulmonary, peritoneal and rare colon metastasis: A case report
320 Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA